Since depression is a microglial disease (Yirmiya et al., 2015), to determine whether CUMS-induced depression and the antidepressant effects of Gps corresponded with regulated microglial state transition, we measured the expression of inflammatory parameters and anti-inflammatory phenotype markers in the hippocampus of treated and control mice. Here, NBEAL2 is linked to depressive symptom measurement.